Radio and PodcastLive Radio & Podcasts

Search Radio and Podcast

Podcasts›Diabetes Core Update›Efficacy and safety of CagriSema & Retatrutide, CGM benefits beyond T2D, & more!

Science & Medicine

Efficacy and safety of CagriSema & Retatrutide, CGM benefits beyond T2D, & more!

Diabetes Core Update by American Diabetes Association

Jun 30, 202634:30Science & Medicine

Welcome to the latest episode (July 2026) of DOC Updates , where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month on DOC U...

Related Episodes

Continue listening to more episodes from Diabetes Core Update.

Special Edition: Hypertension Part 2—Advanced Hypertension Management: Uncontrolled and Resistant Hypertension and the Importance of Aldosterone

Sep 8, 2026 - 39:38

Uncontrolled and resistant hypertension is more common than we think. In the second episode of this speci...

Special Edition: Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Sep 3, 2026 - 22:38

What is the difference between MASH and MASLD? In this special episode, Dr. Neil Skolnik breaks down thes...

Special Edition: Evidence-Based Strategies for Weight Loss and Long-Term Weight Maintenance

Aug 24, 2026 - 32:04

Weight maintenance is a challenging topic for both clinicians and patients. In this special episode, Neil...

Special Edition: What's Next—The Role of Health Systems in Managing CKD Associated with T1D & T2D

Aug 17, 2026 - 33:00

To achieve optimal outcomes for patients, it is not only the individual efforts of clinicians that matter...

Katherine Tuttle on SGLT2s & CKD in T2D, Alexander Turchin on medications after Metformin, and High vs. Low CVD Risk, the ADA's statement on employment and diabetes, and more!

Aug 10, 2026 - 35:49

With the launch of a new journal, the American Diabetes Association (ADA) is also launching a brand new p...